REQUEST A DEMO
Total
USD $0.00
Search more companies

Imp & C Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Imp & C Sp. z o.o. Profile Updated: November 07, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Imp & C Sp. z o.o. is an enterprise located in Poland, with the main office in Warsaw. It operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on January 16, 2019. The company’s latest financial report indicates a net sales revenue drop of 68% in 2023. Its’ total assets recorded a negative growth of 40.06%. The net profit margin of Imp & C Sp. z o.o. decreased by 336.34% in 2023.

Headquarters
Ul. Domaniewska 50
Warsaw; Mazowieckie; Postal Code: 02-672

Contact Details: Purchase the Imp & C Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Imp & C Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Imp & C Sp. z o.o. report to view the information.
Incorporation Date:
January 16, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
75%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Imp & C Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-68%
Total operating revenue
33.75%
Operating profit (EBIT)
38.74%
Net Profit (Loss) for the Period
34.06%
Total assets
-40.06%
Total equity
-18.81%
Operating Profit Margin (ROS)
-264.45%
Net Profit Margin
-336.34%
Return on Equity (ROE)
-12.69%
Quick Ratio
-0%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?